# Glimepiride

## AmaRyl 2mg

| TAH Drug Code      | [**OAMA**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OAMA)                                                                                                                                                                                                                                                                                       |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Type 2 diabetes mellitus.                                                                                                                                                                                                                                                                                                                                      |
| Dosing             | 1-2 mg once daily at breakfast, max 8 mg/day.                                                                                                                                                                                                                                                                                                                  |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                  |
| Contraindications  | Insulin-dependent (type 1) diabetes mellitus; diabetic ketoacidosis; diabetic precoma or coma; serious renal or hepatic dysfunction. Pregnancy, lactation.                                                                                                                                                                                                     |
| Adverse Effects    | Hypoglycaemia; adrenergic counter-regulation; temporary visual impairment; GI symptoms. Rarely thrombopenia, haemolytic anaemia, erythrocytopenia, leucopenia, agranulocytosis. Endocrine metabolic: Hypoglycemia [0.9% to 1.7% (adults); 4% (pediatrics) ] Gastrointestinal: Nausea (1.1% ) Neurologic: Asthenia (1.6% ), Dizziness (1.7% ), Headache (1.5% ) |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                  |

